HOPA President: Networking, In-Person Education Can Change the Course of Oncology Pharmacy Practice
March 24th 2022Larry Buie, PharmD, BCOP, FASHP, outgoing president of the Hematology/Oncology Pharmacy Association (HOPA), shares some details of HOPA’s upcoming 2022 annual conference in Boston and provides an overview of his term as HOPA’s president.
Watch
Interactions to Monitor Between Erectile Dysfunction Drugs and Other Medications
March 24th 2022Many of the medications used in the treatment of erectile dysfunction have interactions with other medications, so it is crucial for pharmacists to carefully examine patient profiles to optimize therapy and ensure safety.
Read More
FDA Approves Pluvicto for PSMA–Positive Metastatic Castration-Resistant Prostate Cancer
March 24th 2022Pluvicto is indicated for the treatment of adults with prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer who were previously administered other anticancer therapies.
Read More
PQA Annual Meeting: Quality Emerges from the Pandemic, Focused on Access and Equity
March 23rd 2022Open to all health care professionals, the PQA meeting is a top forum for learning best practices and emerging trends in medication services, pharmacist-provided care and quality improvement initiatives.
Read More